The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry.
Anthony S PadulaDimitrios A PappasStefano FioreTaylor S BlachleyKerri FordKelechi EmeanuruJoel M KremerPublished in: Arthritis research & therapy (2022)
These real-world results align with the mechanism of IL-6R inhibition and may inform treatment decisions for patients with RA.